Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir

10.1038/nrneph.2009.142

10.1086/598507

Fux CA, 2007, Antivir Ther, 12, 1165, 10.1177/135965350701200812

Izzedine H, 2005, Data from a double-blind randomized active- controlled multicenter study. Nephrol Dial Transplant, 20, 743

10.1016/j.biopha.2007.04.008

10.1086/503566

10.1097/QAD.0b013e3282ef792f

10.7326/0003-4819-145-4-200608150-00004

10.7326/0003-4819-139-2-200307150-00013

10.1186/cc2872

Calza L, 2011, Scand J Infect Dis, 43, 656, 10.3109/00365548.2011.572906

Fernandez-Fernandez B, 2011, AIDS Res Treat, 2011, 354908

10.1053/j.ajkd.2011.01.022

10.1007/978-1-61779-163-5_22

Gayet-Ageron A, 2007, J Antimicrob Chemother, 59, 1034, 10.1093/jac/dkm064

10.1038/ki.2010.318

10.1097/QAD.0b013e32832cbcc2

Viganò A, 2011, Clin Drug Investig, 31, 407, 10.2165/11590400-000000000-00000

Hall AM, 2009, Am J Kidney Dis, 54, 1034, 10.1053/j.ajkd.2009.07.012

Horberg M, 2010, J Acquir Immune Defic Syndr, 53, 62, 10.1097/QAI.0b013e3181be6be2

10.1111/j.1468-1293.2009.00780.x

Mocroft A, 2010, AIDS, 24, 1667, 10.1097/QAD.0b013e328339fe53

Tordato F, 2011, HIV Med, 12, 4, 10.1111/j.1468-1293.2010.00855.x

10.1086/655681

Scherzer R, 2012, AIDS, 26, 867, 10.1097/QAD.0b013e328351f68f

10.1093/jac/dkr039

Vrouenraets SM, 2011, HIV Med, 12, 620, 10.1111/j.1468-1293.2011.00941.x

Albini A, 2012, J Acquir Immune Defic Syndr, 59, 18, 10.1097/QAI.0b013e31823a6124

Rasch MG, Scand J Infect Dis, 2012

10.1097/QAD.0b013e32834f337c

van Griensven J, 2011, J Acquir Immune Defic Syndr, 57, 21, 10.1097/QAI.0b013e3182199f00

10.1097/QAD.0b013e32834bba87

Schmid S, 2007, Virchows Arch, 450, 665, 10.1007/s00428-007-0418-3

Rockwood N, 2011, AIDS, 25, 1671, 10.1097/QAD.0b013e32834a1cd6